Hindy G, Wiberg F, Almgren P, Melander O, Orho-Melander M. Polygenic Risk Score for Coronary Heart Disease Modifies the Elevated Risk by Cigarette Smoking for Disease Incidence. Circ Genom Precis Med. 2018;11(1):e001856. doi:10.1161/CIRCGEN.117.001856
Emdin CA, Khera AV, Natarajan P, et al. Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease. JAMA. 2017;317(6):626-634. doi:10.1001/jama.2016.21042
Saleheen D, Natarajan P, Armean IM, et al. Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity. Nature. 2017;544(7649):235-239. doi:10.1038/nature22034
Emdin CA, Klarin D, Natarajan P, et al. Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease. Diabetes. 2017;66(8):2310-2315. doi:10.2337/db17-0149
Noseworthy PA, Peloso GM, Hwang SJ, et al. QT interval and long-term mortality risk in the Framingham Heart Study. Ann Noninvasive Electrocardiol. 2012;17(4):340-8. doi:10.1111/j.1542-474X.2012.00535.x
Peloso GM, Auer PL, Bis JC, et al. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am J Hum Genet. 2014;94(2):223-32. doi:10.1016/j.ajhg.2014.01.009
TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute, Crosby J, Peloso GM, et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med. 2014;371(1):22-31. doi:10.1056/NEJMoa1307095
Kathiresan S. Developing medicines that mimic the natural successes of the human genome: lessons from NPC1L1, HMGCR, PCSK9, APOC3, and CETP. J Am Coll Cardiol. 2015;65(15):1562-6. doi:10.1016/j.jacc.2015.02.049
Mukamal KJ, Jensen MK, Pers TH, Pai JK, Kraft P, Rimm EB. Multilocus heterozygosity and coronary heart disease: nested case-control studies in men and women. PLoS One. 2015;10(5):e0124847. doi:10.1371/journal.pone.0124847
Keenan T, Zhao W, Rasheed A, et al. Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study. J Am Coll Cardiol. 2016;67(4):407-16. doi:10.1016/j.jacc.2015.10.086